gvtcx

NHS National Framework for Generic Pharmaceuticals - Wave 12

NHS England Published 15 May 2019 Contracts Finder
The value below is a framework or dynamic market ceiling: the maximum that could be spent across all call-offs, not the value of a single contract. Aggregate figures on this site exclude these to avoid double counting.

key details

Value£349,520,580
Statuscomplete
Category (CPV) 33900000 +1 more
RegionNorth East, North West, Yorkshire and the Humber, East Midlands, West Midlands, East of England, London, South East, South West
Deadline18 Jun 2019
Contract start1 Feb 2020
Contract end31 Jan 2022
Procedureopen
SME suitableYes
OCIDocds-b5fd17-eec63448-4bc7-4668-b977-d199e548e2a9

Award

SupplierValueDateStatus
Please see list of awarded suppliers (including SME status) at t £349,520,580 13 Oct 2019 active

description

Award details for NHS National Framework for Generic Pharmaceuticals - Wave 12

Offer reference number: CM/PHG/17/5531

Period of framework agreement: The total maximum duration of the framework agreement to be no more than 48 months

Potential periods of call-offs under the framework agreement:

Hospital Only Products -

DLS/DNE/DNW regions: 01/02/2020 to 31/01/2022 (24 months)

DLN/DCE/DSW regions: 01/02/2020 to 31/01/2021 (12 months)

Oral Products (100%) all regions: 01/02/2020 to 28/02/2021 (13 months)

documents

Documents are linked, not mirrored. They are served by the publishing authority and may require registration.

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
27 Dec 2019 Award (award) · cd1c7037-987d-4940-9145-d1d7173aaa42-334515

more from NHS England

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.